A5017513314- Diabetes Treatment and Management
- Diabetes Management and Research
- Healthcare Systems and Practices
- Health Systems, Economic Evaluations, Quality of Life
- Diabetes Management and Education
- Health, Medicine and Society
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmaceutical Economics and Policy
- Diabetes and associated disorders
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pharmacology and Obesity Treatment
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Chronic Disease Management Strategies
- Clinical practice guidelines implementation
- Cervical Cancer and HPV Research
- Multiple Sclerosis Research Studies
- Metabolism, Diabetes, and Cancer
- Asthma and respiratory diseases
- Global Health Care Issues
- Venous Thromboembolism Diagnosis and Management
- Economic and Financial Impacts of Cancer
- Viral gastroenteritis research and epidemiology
- Medication Adherence and Compliance
- Emergency and Acute Care Studies
- Global Cancer Incidence and Screening
Cemka-Eval (France)
2016-2025
Société Francophone du Diabète
2021-2023
Veolia (France)
2006
Veolia (Norway)
2006
Ministère des Solidarités et de la Santé
2006
Hôpital Cochin
2003
Fonds National de la Recherche
1995
OBJECTIVE—The aim of this study was to assess the characteristics and care patients with diabetes in countries a sizable Muslim population features during Ramadan effect fasting. RESEARCH DESIGN AND METHODS—This population-based, retrospective, transversal survey conducted 13 countries. A total 12,914 were recruited using stratified sampling method, 12,243 considered for analysis. RESULTS—Investigators 1,070 (8.7%) type 1 11,173 (91.3%) 2 diabetes. During Ramadan, 42.8% 78.7% fasted at least...
OBJECTIVE The RELIEF study assessed rates of hospitalization for acute diabetes complications in France before and after initiation the FreeStyle Libre system. RESEARCH DESIGN AND METHODS A total 74,011 patients with type 1 or 2 who initiated system were identified from French national claims database use ICD-10 codes, hospitalizations as a contributing diagnosis, prescription insulin. Patients subclassified based on self-monitoring blood glucose (SMBG) strip acquisition prior to starting...
Abstract Objective To analyze specific clinical findings, underlying disorders, treatments, outcomes, and prognostic factors for reactive hemophagocytic syndrome (RHS) in systemic disease. Methods Data were collected using standardized forms as part of a French national survey. Adult cases without an malignancy, diagnosed on bone marrow or lymph node biopsy, included. Results Twenty‐six (7 men, 19 women, mean age 47.4 ± 17.7 years) studied. Systemic diseases included lupus erythematosus (n =...
Abstract Background Current asthma management guidelines are based on the level of control. The impact control health care resources and quality life (QoL) is insufficiently studied. EUCOAST study was designed to describe costs QoL in adult patients according France Spain. Methods An observational cost illness conducted simultaneously both countries among age greater or equal 18 with a diagnosis for at least 12 months. Patients were recruited prospectively by GPs 2010 four waves avoid...
Aims/Hypothesis: Initiation of insulin therapy in people with type 2 diabetes (T2DM) may be necessary to achieve glycemic targets but is associated acute events (ADEs), including severe hypoglycemia (SH) or diabetic ketoacidosis (DKA). We assessed the impact initiating FreeStyle Libre® system (FSL) on hospitalizations for ADEs T2DM basal only regimen±noninsulin antidiabetic drugs. Materials and Methods: A retrospective study French national Système National des Données de Santé reimbursement...
Background: The RELIEF study has previously shown a fall in the rate of acute diabetes events (ADEs) people living with type 1 (PwDT1) or 2 (PwDT2) 12 months after initiation flash glucose monitoring (FLASH) France. 2-year follow-up provided new insights on frequency ADEs, including severe hypoglycemia and diabetic ketoacidosis (DKA), during use FLASH. Methods: included 31,446 PwDT1 41,027 PwDT2 first delivery FreeStyle Libre (FSL) between August December 31, 2017. Hospitalizations for DKA,...
Background and Aims: Older people with type 2 diabetes (T2DM) on insulin are at increased risk of hypoglycemia associated morbidity. Management T2DM in older must optimize glycemic control, while minimizing risks for diabetic ketoacidosis (DKA). In France, the FreeStyle Libre® (FSL) system has been reimbursed since June 2017 intensive therapy. We assessed impact starting FSL hospitalizations acute events (ADEs) ≥65 years old, Materials Methods: A retrospective study French Système National...
Abstract Aim To describe the association between socio‐economic position, health status and quality of diabetes care in people with Type 2 France, where may receive full healthcare coverage for chronic disease. Methods Data from a national cross‐sectional survey performed pharmacologically treated were used. They combined data medical claims, hospital discharge, questionnaires patients ( n = 3894 diabetes) their physicians 2485). Socio‐economic position was assessed using educational level...
Two randomised controlled trials (RCTs) have previously shown that telemedical monitoring of diabetic foot ulcer (DFU) reduces the number visits to outpatient clinic, without losing treatment efficacy or increasing costs. Here we present results an open-label, trial designed investigate whether telemonitoring, provided by expert nurse (with extensive experience in DFU and trained remote monitoring), hospital stay associated costs for a patient with (TELEPIED trial).Eligible patients (n =...
Our study aims to uncover glycaemic phenotype heterogeneity in type 1 diabetes.
Introduction Several cardiovascular outcome trials have been conducted to assess the safety and efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RAs) on cardiorenal outcomes in patients with type-2 diabetes (T2D). However, strict requirements randomised controlled avoid most confounding factors are at expense external validity. Using national real-world data, we aimed evaluate effectiveness GLP-1RAs association metformin especially events, hospitalisation for heart failure...
Our objects was to estimate the direct healthcare costs of type 2 diabetes mellitus (T2DM) in France 2013. Data were drawn from a random sample ≈600,000 patients registered French national health insurances database, which covers 90% population. An algorithm used select with T2DM. Direct collective perspective derived database and compared those control group cost related comorbidities. Overall also according therapies throughout year Cost analysis available for 25,987 T2DM (mean age 67.5 ±...
The objective of this study was to document the initiation insulin therapy in patients with type 2 diabetes mellitus (T2DM) and its maintenance as a function time after French nationwide representative cohort.A retrospective cohort conducted on random sample ~600,000 beneficiaries registered national health insurance database. Newly treated T2DM were selected. Persistence defined remaining without discontinuation (defined over 6 or 12-month period).Among 1909 initiations identified 2012/2013...
Background: The DIABEO® system (DS) is a telemedicine solution that combines mobile app for patients with web portal health care providers. DS allows real-time monitoring of basal-bolus insulin therapy as well therapeutic decision-making, integrating both basal and bolus dose calculation. Real-life studies have shown very low rate use applications by patients. Therefore, we conducted large randomized controlled trial study to investigate the efficacy in conditions close real life (TELESAGE...
France has included health economic assessment (HEA) as an official criterion for innovative drug pricing since 2013. Until now, no cost-effectiveness threshold (CET) been officially proposed to qualify incremental ratios (ICERs). Although the French authorities have publicly expressed need such reference values, previous initiatives determine these failed. The study aims propose a locally adapted method estimating preference-based value quality-adjusted life-year (QALY) based on rational...